Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 08:25 ET | Source: Viewbix Inc.

Viewbix: Quantum X Labs Announces Breakthrough in the Development of a Quantum Gyroscope Chip Technology

The global quantum compass navigation is expected to experience robust growth in the upcoming years Tel Aviv, Israel, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the...
January 06, 2026 08:19 ET | Source: Coeptis Therapeutics

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, , announced...
January 06, 2026 08:15 ET | Source: Ernexa Therapeutics Inc.

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian...
January 06, 2026 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum today...
January 06, 2026 08:05 ET | Source: VivoSim Labs, Inc.

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing...
January 06, 2026 08:03 ET | Source: Treasure Global Inc.

Treasure Global Concludes Alumni Capital Equity Line Facility to Streamline Capital Structure and Focus on Fintech & Digital-Asset Growth

KUALA LUMPUR, Malaysia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced the...
January 06, 2026 08:01 ET | Source: Skyworks Solutions, Inc.

Skyworks Showcases Intelligent Connectivity Innovations at CES 2026

LAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS) introduced the SKY66424-11, the industry’s first highly integrated Wi-SUN®/LoRaWAN® RF front-end modules (FEM)...
January 06, 2026 08:00 ET | Source: CAMP4 Therapeutics

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...
January 06, 2026 08:00 ET | Source: Akebia Therapeutics, Inc.

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
January 06, 2026 08:00 ET | Source: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across multiple sites Reached written alignment with FDA on...